-
Full Article (HTML) (259) -
Full Article (PDF) (102) -
Send to Friends (0)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Checklist of Responsibilities for the Scientific Editor of This Article
Publishing Process of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (15194)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Feb 14, 2017 (publication date) through Oct 4, 2022
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Matsubayashi H, Takaori K, Morizane C, Maguchi H, Mizuma M, Takahashi H, Wada K, Hosoi H, Yachida S, Suzuki M, Usui R, Furukawa T, Furuse J, Sato T, Ueno M, Kiyozumi Y, Hijioka S, Mizuno N, Terashima T, Mizumoto M, Kodama Y, Torishima M, Kawaguchi T, Ashida R, Kitano M, Hanada K, Furukawa M, Kawabe K, Majima Y, Shimosegawa T. Familial pancreatic cancer: Concept, management and issues. World J Gastroenterol 2017; 23(6): 935-948 [PMID: 28246467 DOI: 10.3748/wjg.v23.i6.935] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i6/935.htm |
| Number | Citing Articles |
| 1 |
Mu-jing Ke, Lian-dong Ji, Yi-xiong Li. Bioinformatics analysis combined with experiments to explore potential prognostic factors for pancreatic cancer. Cancer Cell International 2020; 20(1) doi: 10.1186/s12935-020-01474-7
|
| 2 |
Mathias Cavaillé, Nancy Uhrhammer, Maud Privat, Flora Ponelle‐Chachuat, Mathilde Gay‐Bellile, Mathis Lepage, Sandrine Viala, Yannick Bidet, Yves‐Jean Bignon. Feedback of extended panel sequencing in 1530 patients referred for suspicion of hereditary predisposition to adult cancers. Clinical Genetics 2021; 99(1): 166 doi: 10.1111/cge.13864
|
| 3 |
Hideki Shimmura, Hidekazu Kuramochi, Norie Jibiki, Satoshi Katagiri, Takayoshi Nishino, Tatsuo Araida. Dramatic response of FOLFIRINOX regimen in a collision pancreatic adenocarcinoma patient with a germline BRCA2 mutation: a case report. Japanese Journal of Clinical Oncology 2019; 49(11): 1049 doi: 10.1093/jjco/hyz141
|
| 4 |
Nuria Garcia-Carbonero, Weiyao Li, Marticela Cabeza-Morales, Javier Martinez-Useros, Jesus Garcia-Foncillas. New Hope for Pancreatic Ductal Adenocarcinoma Treatment Targeting Endoplasmic Reticulum Stress Response: A Systematic Review. International Journal of Molecular Sciences 2018; 19(9): 2468 doi: 10.3390/ijms19092468
|
| 5 |
Mohamed M. Gad, Anas M. Saad, Muneer J. Al-Husseini, Youssef M. Abdel-Gawad, Obai M. Alsalhani, Razan Alhaddad, Bashar Mohamad, Mohannad Abou Saleh, Carlos Roberto Simons-Linares. Temporal trends of pancreatic ductal adenocarcinoma in young adults in the United States: A Population-Based Study. Clinics and Research in Hepatology and Gastroenterology 2020; 44(2): 204 doi: 10.1016/j.clinre.2019.07.001
|
| 6 |
Sergio Carrera, Aintzane Sancho, Eider Azkona, Josune Azkuna, Guillermo Lopez-Vivanco. Hereditary pancreatic cancer: related syndromes and clinical perspective. Hereditary Cancer in Clinical Practice 2017; 15(1) doi: 10.1186/s13053-017-0069-6
|
| 7 |
Sojun Hoshimoto, Shoichi Hishinuma, Hirofumi Shirakawa, Moriaki Tomikawa, Iwao Ozawa, Yoshiro Ogata. Outcomes in patients with pancreatic cancer as a secondary malignancy: a retrospective single-institution study. Langenbeck's Archives of Surgery 2019; 404(8): 975 doi: 10.1007/s00423-019-01841-7
|
| 8 |
Katja Steiger, Anna-Melissa Schlitter, Wilko Weichert, Irene Esposito, Hans-Jürgen Wester, Johannes Notni. Perspective of αvβ6-Integrin Imaging for Clinical Management of Pancreatic Carcinoma and Its Precursor Lesions. Molecular Imaging 2017; 16: 153601211770938 doi: 10.1177/1536012117709384
|
| 9 |
Julia Benzel, Volker Fendrich. Familial Pancreatic Cancer. Oncology Research and Treatment 2018; 41(10): 611 doi: 10.1159/000493473
|
| 10 |
Naohiro Okano, Chigusa Morizane, Shogo Nomura, Hideaki Takahashi, Hidetaka Tsumura, Hironaga Satake, Nobumasa Mizuno, Kunihiro Tsuji, Kazuhiko Shioji, Akinori Asagi, Kohichiroh Yasui, Sho Kitagawa, Tomomi Kashiwada, Atsushi Ishiguro, Masashi Kanai, Makoto Ueno, Takashi Ogura, Satoshi Shimizu, Kazutoshi Tobimatsu, Masayo Motoya, Koji Nakashima, Masafumi Ikeda, Takuji Okusaka, Junji Furuse. Phase II clinical trial of gemcitabine plus oxaliplatin in patients with metastatic pancreatic adenocarcinoma with a family history of pancreatic/breast/ovarian/prostate cancer or personal history of breast/ovarian/prostate cancer (FABRIC study). International Journal of Clinical Oncology 2020; 25(10): 1835 doi: 10.1007/s10147-020-01721-x
|
| 11 |
Hironori Hayashi, Koji Amaya, Tomokazu Tokoro, Kosuke Mori, Shunsuke Takenaka, Yuya Sugimoto, Yuto Kitano, Toru Kurata, Shunsuke Kawai, Atsushi Hirose, Tomoya Tsukada, Masahide Kaji, Koichi Shimizu, Kiichi Maeda. Clinical features of patients with pancreatic ductal adenocarcinoma with a history of other primary malignancies: A retrospective analysis. Molecular and Clinical Oncology 2021; 15(3) doi: 10.3892/mco.2021.2335
|
| 12 |
Parnia Rahnamay Farnood, Romina Danesh Pazhooh, Zatollah Asemi, Bahman Yousefi. DNA damage response and repair in pancreatic cancer development and therapy. DNA Repair 2021; 103: 103116 doi: 10.1016/j.dnarep.2021.103116
|
| 13 |
Qisthina Syifa Setiawan, Zuherman Rustam, Sri Hartini, Velery Virgina Putri Wibowo, Jane Eva Aurelia. Comparing Decision Tree and Logistic Regression for Pancreatic Cancer Classification. 2020 International Conference on Decision Aid Sciences and Application (DASA) 2020; : 623 doi: 10.1109/DASA51403.2020.9317036
|
| 14 |
Lucia Liotta, Sebastian Lange, H. Carlo Maurer, Kenneth P. Olive, Rickmer Braren, Nicole Pfarr, Sebastian Burger, Alexander Muckenhuber, Moritz Jesinghaus, Katja Steiger, Wilko Weichert, Helmut Friess, Roland Schmid, Hana Algül, Philipp J. Jost, Juliane Ramser, Christine Fischer, Anne S. Quante, Maximilian Reichert, Michael Quante. PALLD mutation in a European family conveys a stromal predisposition for familial pancreatic cancer. JCI Insight 2021; 6(8) doi: 10.1172/jci.insight.141532
|
| 15 |
Satomi Higashigawa, Hiroyuki Matsubayashi, Yoshimi Kiyozumi, Nobuhiro Kado, Seiichiro Nishimura, Takuma Oishi, Takashi Sugino, Kunihiro Fushiki, Hiromichi Shirasu, Hirofumi Yasui, Nobuaki Mamesaya, Naomi Fukuzaki, Kana Kunitomo, Yasue Horiuchi, Hirotsugu Kenmotsu, Masakuni Serizawa. Present status of germline findings in precision medicine for Japanese cancer patients: issues in the current system. Japanese Journal of Clinical Oncology 2022; 52(6): 599 doi: 10.1093/jjco/hyac046
|
| 16 |
Renato Cannizzaro, Raffaella Magris, Stefania Maiero, Giovanni Guarnieri, Mara Fornasarig, Vincenzo Canzonieri. Endoscopic Ultrasound Management of Pancreatic Lesions. 2021; : 149 doi: 10.1007/978-3-030-71937-1_11
|
| 17 |
Takeshi Terashima, Chigusa Morizane, Mineko Ushiama, Satoshi Shiba, Hideaki Takahashi, Masafumi Ikeda, Nobumasa Mizuno, Kunihiro Tsuji, Kohichiroh Yasui, Nobuaki Azemoto, Hironaga Satake, Shogo Nomura, Shinichi Yachida, Kokichi Sugano, Junji Furuse. Germline variants in cancer-predisposing genes in pancreatic cancer patients with a family history of cancer. Japanese Journal of Clinical Oncology 2022; doi: 10.1093/jjco/hyac110
|
| 18 |
|
| 19 |
Sarah K. Macklin, Pashtoon M. Kasi, Jessica L. Jackson, Stephanie L. Hines. Incidence of Pathogenic Variants in Those With a Family History of Pancreatic Cancer. Frontiers in Oncology 2018; 8 doi: 10.3389/fonc.2018.00330
|
| 20 |
Surveillance of Individuals with a Family History of Pancreatic Cancer and Inherited Cancer Syndromes: A Strategy for Detecting Early Pancreatic Cancers. Diagnostics 2019; 9(4): 169 doi: 10.3390/diagnostics9040169
|
| 21 |
David J. Easty, Christine J. Farr, Bryan T. Hennessy. New Roles for Vitamin D Superagonists: From COVID to Cancer. Frontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.644298
|
| 22 |
Hidetoshi Eguchi, Shogo Kobayashi, Kunihito Gotoh, Takehiro Noda, Yuichiro Doki. Characteristics of early‐onset pancreatic cancer and its association with familial pancreatic cancer and hereditary pancreatic cancer syndromes. Annals of Gastroenterological Surgery 2020; 4(3): 229 doi: 10.1002/ags3.12326
|
| 23 |
Maria J. Monroy-Iglesias, Saoirse Dolly, Debashis Sarker, Kiruthikah Thillai, Mieke Van Hemelrijck, Aida Santaolalla. Pancreatic Cancer Exposome Profile to Aid Early Detection and Inform Prevention Strategies. Journal of Clinical Medicine 2021; 10(8): 1665 doi: 10.3390/jcm10081665
|
| 24 |
Talia Golan, Hedy L. Kindler, Joon Oh Park, Michele Reni, Teresa Macarulla, Pascal Hammel, Eric Van Cutsem, Dirk Arnold, Daniel Hochhauser, David McGuinness, Gershon Y. Locker, Teodora Goranova, Philipp Schatz, Yu-Zhen Liu, Michael J. Hall. Geographic and Ethnic Heterogeneity of Germline BRCA1 or BRCA2 Mutation Prevalence Among Patients With Metastatic Pancreatic Cancer Screened for Entry Into the POLO Trial. Journal of Clinical Oncology 2020; 38(13): 1442 doi: 10.1200/JCO.19.01890
|
| 25 |
Maria Teresa Vietri, Giovanna D’Elia, Gemma Caliendo, Luisa Albanese, Giuseppe Signoriello, Claudio Napoli, Anna Maria Molinari. Pancreatic Cancer with Mutation in BRCA1/2, MLH1, and APC Genes: Phenotype Correlation and Detection of a Novel Germline BRCA2 Mutation. Genes 2022; 13(2): 321 doi: 10.3390/genes13020321
|
| 26 |
Negesse Mekonnen, Hobin Yang, Young Kee Shin. Homologous Recombination Deficiency in Ovarian, Breast, Colorectal, Pancreatic, Non-Small Cell Lung and Prostate Cancers, and the Mechanisms of Resistance to PARP Inhibitors. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.880643
|
| 27 |
Stanisław Głuszek, Artur Kowalik, Dorota Kozieł, Iwona Wawrzycka, Martyna Głuszek-Osuch, Jarosław Matykiewicz. CTRC gene polymorphism may increase pancreatic cancer risk – preliminary study. Polish Journal of Surgery 2017; 89(5): 48 doi: 10.5604/01.3001.0010.5411
|
| 28 |
Susumu Hijioka, Chigusa Morizane, Kyoichi Takaori, Takuji Okusaka. Study protocol for a multi-institutional prospective surveillance study among kindreds with familial pancreatic cancer and individuals with hereditary pancreatic cancer syndrome: The Diamond Study. Pancreatology 2022; 22(4): 534 doi: 10.1016/j.pan.2022.04.006
|
| 29 |
Zohar Levi, Yakir Rottenberg, Gilad Twig, Lior Katz, Adi Leiba, Estela Derazne, Dorit Tzur, Sapir Eizenstein, Lital Keinan-Boker, Arnon Afek, Jeremy Dan Kark. Adolescent overweight and obesity and the risk for pancreatic cancer among men and women: a nationwide study of 1.79 million Israeli adolescents. Cancer 2019; 125(1): 118 doi: 10.1002/cncr.31764
|
| 30 |
Vincent C. Henrich, Lori A. Orlando, Brian H. Shirts. Managing Patient Health in the Genomic Era. 2020; : 105 doi: 10.1016/B978-0-12-816015-2.00005-5
|
| 31 |
C. Kahlert, M. Distler, D. Aust, L. Gieldon, J. Weitz, T. Welsch. Pankreasfrühkarzinom. Der Chirurg 2018; 89(4): 257 doi: 10.1007/s00104-017-0569-y
|
| 32 |
Kinuko Ohneda, Yohei Hamanaka, Hiroshi Kawame, Nobuo Fuse, Fuji Nagami, Yoichi Suzuki, Yumi Yamaguchi-Kabata, Muneaki Shimada, Atsushi Masamune, Yoko Aoki, Takanori Ishida, Masayuki Yamamoto. Returning individual genomic results to population-based cohort study participants with BRCA1/2 pathogenic variants. Breast Cancer 2022; doi: 10.1007/s12282-022-01404-7
|
| 33 |
Akimasa Hayashi, Jungeui Hong, Christine A. Iacobuzio-Donahue. The pancreatic cancer genome revisited. Nature Reviews Gastroenterology & Hepatology 2021; 18(7): 469 doi: 10.1038/s41575-021-00463-z
|
| 34 |
C. Langner. Hereditäres Magen- und Pankreaskarzinom. Der Pathologe 2017; 38(3): 164 doi: 10.1007/s00292-017-0297-6
|
| 35 |
Loveena Sreedharan, Bhaskar Kumar, Anna Jewell, Paul Banim, Andreas Koulouris, Andrew R Hart. Bridging clinic: The initial medical management of patients with newly diagnosed pancreatic cancer. Frontline Gastroenterology 2019; 10(3): 261 doi: 10.1136/flgastro-2018-101002
|
| 36 |
Nicola Silvestris, Oronzo Brunetti, Alessandro Bittoni, Ivana Cataldo, Domenico Corsi, Stefano Crippa, Mirko D’Onofrio, Michele Fiore, Elisa Giommoni, Michele Milella, Raffaele Pezzilli, Enrico Vasile, Michele Reni. Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up of Exocrine Pancreatic Ductal Adenocarcinoma: Evidence Evaluation and Recommendations by the Italian Association of Medical Oncology (AIOM). Cancers 2020; 12(6): 1681 doi: 10.3390/cancers12061681
|
| 37 |
Julie Earl, Cristina Galindo-Pumariño, Jessica Encinas, Emma Barreto, Maria E. Castillo, Vanessa Pachón, Reyes Ferreiro, Mercedes Rodríguez-Garrote, Silvia González-Martínez, Teresa Ramon y Cajal, Luis Robles Diaz, Isabel Chirivella-Gonzalez, Montse Rodriguez, Eva Martínez de Castro, David García-Seisdedos, Gloria Muñoz, Juan Manuel Rosa Rosa, Mirari Marquez, Nuría Malats, Alfredo Carrato. A comprehensive analysis of candidate genes in familial pancreatic cancer families reveals a high frequency of potentially pathogenic germline variants. EBioMedicine 2020; 53: 102675 doi: 10.1016/j.ebiom.2020.102675
|
| 38 |
Kodai Abe, Minoru Kitago, Yuko Kitagawa, Akira Hirasawa. Hereditary pancreatic cancer. International Journal of Clinical Oncology 2021; 26(10): 1784 doi: 10.1007/s10147-021-02015-6
|
| 39 |
Akihiro Ohmoto, Shinichi Yachida, Chigusa Morizane. Genomic Features and Clinical Management of Patients with Hereditary Pancreatic Cancer Syndromes and Familial Pancreatic Cancer. International Journal of Molecular Sciences 2019; 20(3): 561 doi: 10.3390/ijms20030561
|
| 40 |
Masayuki KITANO, Chigusa MORIZANE, Susumu HIJIOKA, Hiroyuki MATSUBAYASHI, Reiko ASHIDA, Tsukasa IKEURA, Tetsuhide ITO, Terumi KAMISAWA, Takahisa KAWAGUCHI, Ken KAWABE, Shinji KOSUGI, Yuzo KODAMA, Kyoko SHIMIZU, Hideaki TAKAHASHI, Shinichi YACHIDA, Takeshi TERASHIMA, Masako TORISHIMA, Keiji HANADA, Toru FURUKAWA, Masayuki FURUKAWA, Junji FURUSE, Hiroyuki MAGUCHI, Yoshiyuki MAJIMA, Nobumasa MIZUNO, Masamichi MIZUMA, Masaki MIZUMOTO, Takeichi YOSHIDA, Keita WADA, Kyoichi TAKAORI. Surveillance for the early diagnosis of familial pancreatic cancer (Expert consensus). Suizo 2020; 35(4): 322 doi: 10.2958/suizo.35.322
|
| 41 |
Tsuyoshi Hamada, Chen Yuan, Matthew B. Yurgelun, Kimberly Perez, Natalia Khalaf, Vicente Morales-Oyarvide, Ana Babic, Jonathan A. Nowak, Douglas A. Rubinson, Marios Giannakis, Kimmie Ng, Peter Kraft, Meir J. Stampfer, Edward L. Giovannucci, Charles S. Fuchs, Shuji Ogino, Brian M. Wolpin. Family history of cancer, Ashkenazi Jewish ancestry, and pancreatic cancer risk. British Journal of Cancer 2019; 120(8): 848 doi: 10.1038/s41416-019-0426-5
|
| 42 |
Eleonora Molinaro, Kalliopi Andrikou, Andrea Casadei-Gardini, Giulia Rovesti. BRCA in Gastrointestinal Cancers: Current Treatments and Future Perspectives. Cancers 2020; 12(11): 3346 doi: 10.3390/cancers12113346
|
| 43 |
Norman Schöffel, Henryk Thielemann. Die Ärztliche Begutachtung. Springer Reference Medizin 2022; : 1 doi: 10.1007/978-3-662-61937-7_69-1
|
| 44 |
Muhammet Ozer, Megha Ranganathan, Nicolas Lecomte, Juan M. Schvartzman, Henry S. Walch, Walid K. Chatila, Jungeui Hong, Maria I. Carlo, Michael F. Walsh, Margaret Sheehan, Diana Mandelker, Ozge Ceyhan-Birsoy, Anna Maio, Yelena Kemel, Christine A. Iacobuzio-Donahue, Eileen M. O'Reilly, Kenneth H. Yu. Concurrent Germline BRCA1/2 and Mismatch Repair Mutations in Young-Onset Pancreatic and Colorectal Cancer: The Importance of Comprehensive Germline and Somatic Characterization to Inform Therapeutic Options. JCO Precision Oncology 2022; (6) doi: 10.1200/PO.21.00560
|
| 45 |
Siddhartha Yadav, Pashtoon M. Kasi, William R. Bamlet, Thanh P. Ho, Eric C. Polley, Chunling Hu, Steven N. Hart, Kari G. Rabe, Nicholas J. Boddicker, Rohan D. Gnanaolivu, Kun Y. Lee, Tricia H. Lindstrom, Gloria M. Petersen, Fergus J. Couch, Robert R. McWilliams. Effect of Germline Mutations in Homologous Recombination Repair Genes on Overall Survival of Patients with Pancreatic Adenocarcinoma. Clinical Cancer Research 2020; 26(24): 6505 doi: 10.1158/1078-0432.CCR-20-1788
|
| 46 |
Julie Earl, Emma Barreto, María Castillo, Raquel Fuentes, Mercedes Rodríguez-Garrote, Reyes Ferreiro, Pablo Reguera, Gloria Muñoz, David Garcia-Seisdedos, Jorge López, Bruno Sainz, Nuria Malats, Alfredo Carrato. Somatic Mutation Profiling in the Liquid Biopsy and Clinical Analysis of Hereditary and Familial Pancreatic Cancer Cases Reveals KRAS Negativity and a Longer Overall Survival. Cancers 2021; 13(7): 1612 doi: 10.3390/cancers13071612
|
| 47 |
Masanori Abe, Satoshi Takeji, Keitaro Kawasaki, Takatoshi Murakami, Yohei Kashimoto, Shin Yamamoto, Kenji Bando, Norio Horiike, Teru Kumagi. Familial Pancreatic Cancer at Elderly Siblings in Japan. Euroasian Journal of Hepato-Gastroenterology 2019; 9(1): 52 doi: 10.5005/jp-journals-10018-1296
|
| 48 |
Jochen Rädle. Prävention gastroenterologischer Tumorerkrankungen. 2020; : 149 doi: 10.1007/978-3-662-58879-6_9
|
| 49 |
Jun Ushio, Atsushi Kanno, Eriko Ikeda, Kozue Ando, Hiroki Nagai, Tetsurou Miwata, Yuki Kawasaki, Yamato Tada, Kensuke Yokoyama, Norikatsu Numao, Kiichi Tamada, Alan Kawarai Lefor, Hironori Yamamoto. Pancreatic Ductal Adenocarcinoma: Epidemiology and Risk Factors. Diagnostics 2021; 11(3): 562 doi: 10.3390/diagnostics11030562
|
| 50 |
Ernesto Barzola Navarro, Emilio Vicente López, Yolanda Quijano, Riccardo Caruso, Valentina Ferri, Hipolito Durand, Isabel Fabra Cabrera, Eduardo Diaz Reques, Benedetto Ielpo, Anastasiia Yuriyivna Glagolieva, Carlos Plaza. Impact of BRCA1/2 gene mutations on survival of patients with pancreatic cancer: A case-series analysis. Annals of Hepato-Biliary-Pancreatic Surgery 2019; 23(2): 200 doi: 10.14701/ahbps.2019.23.2.200
|
| 51 |
Noor Muhammad, Rida Sadaqat, Humaira Naeemi, Iqra Masood, Usman Hassan, Bushra Ijaz, Faisal Hanif, Aamir A. Syed, Muhammed A. Yusuf, Muhammad U. Rashid. Contribution of germline PALB2 variants to an unselected and prospectively registered pancreatic cancer patient cohort in Pakistan. HPB 2022; doi: 10.1016/j.hpb.2022.09.003
|
| 52 |
Hiroyuki Matsubayashi, Kyoichi Takaori, Chigusa Morizane, Yoshimi Kiyozumi. Familial Pancreatic Cancer and Surveillance of High-Risk Individuals. Gut and Liver 2019; 13(5): 498 doi: 10.5009/gnl18449
|
| 53 |
Junji Furuse. Paradigm Shifting of Systemic Chemotherapy for Unresectable Pancreatic Cancer in Japan. Journal of Clinical Medicine 2019; 8(8): 1170 doi: 10.3390/jcm8081170
|
| 54 |
Fiona Campbell, Caroline S. Verbeke. Pathology of the Pancreas. 2021; : 77 doi: 10.1007/978-3-030-49848-1_6
|
| 55 |
Hiroyuki Matsubayashi, Hirotoshi Ishiwatari, Keiko Sasaki, Katsuhiko Uesaka, Hiroyuki Ono. Detecting Early Pancreatic Cancer: Current Problems and Future Prospects. Gut and Liver 2020; 14(1): 30 doi: 10.5009/gnl18491
|
| 56 |
Kartik Viswanathan, Rema Rao. Pancreas and Biliary Tract Cytohistology. Essentials in Cytopathology 2019; 28: 95 doi: 10.1007/978-3-030-22433-2_5
|
| 57 |
Minseob Kim, Hongbeom Kim, Youngmin Han, Heeju Sohn, Mirang Lee, Yoon Hyung Kang, Hyeong Seok Kim, Wooil Kwon, Jin‐Young Jang. The incidence and clinical features of familial pancreatic cancer in Korea. Journal of Hepato-Biliary-Pancreatic Sciences 2022; 29(6): 659 doi: 10.1002/jhbp.1117
|